Research Focus

Former Employee. MEDICINE; Clin Trials Office Coord

Recent additions – View all

1. Vaccination of patients with chronic myelogenous leukemia using leukemia-specific BCR-ABL breakpoint fusion peptides

   Meeting Abstract

   Scheinberg, D. A.; Bocchia, M.; Koronstvit, T.; Caggiano, J.; Weiss, M.; Kolitz, J.; Megherian, L.; George, D.
   Blood (1996)

   Fulltext@MSK | Save
2. Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy

   Meeting Abstract

   Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
   Blood (1996)

   Fulltext@MSK | Save
3. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

   Journal Article

   Weiss, M.; Maslak, P.; Feldman, E.; Berman, E.; Bertino, J.; Gee, T.; Megherian, L.; Seiter, K.; Scheinberg, D.; Golde, D.
   Journal of Clinical Oncology (1996)

   Fulltext@MSK | Save